Identification of Lenvima:
No description |
Search images on Google Product Monograph
Active Ingredients:
- lenvatinib (lenvatinib mesylate), 4 MG/DOSE
DIN: 02484056
Dosage Form(s): CAPSULE
Route(s) of Administration: ORAL
Schedule: Prescription
Company: EISAI LIMITED
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01E - (ATC, WHO)
- L01EX - (ATC, WHO)
- L01EX08 - LENVATINIB (WHO)
Pharmaceutical standard: MFR